We are live on
!
Find out more
IMA
ImageneBio Inc
Fund managers haven’t disclosed any holdings of IMA yet.
IMA Hedge Fund Activity: Q1 2026 in Review
39 of the 8,133 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q1 2026, worth a combined $26.8M — down 19% from $32.9M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of IMA and 7 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 17 added.
The largest buyer was BVF Inc, adding an estimated $2M. The largest seller was Monashee Investment Management, exiting entirely with an estimated $632K sold.
- 39 institutional investors held ImageneBio Inc (IMA) as of Q1 2026, down from 41 in Q4 2025.
- Funds reported $26.8M of ImageneBio Inc stock for Q1 2026, down 19% quarter-over-quarter.
- 7 funds opened new ImageneBio Inc positions in Q1 2026 and 8 closed out, a net change of -1 holder.
- The largest ImageneBio Inc buyer in Q1 2026 was BVF Inc, an estimated $2M added.
- The largest ImageneBio Inc seller in Q1 2026 was Monashee Investment Management, an estimated $632K sold.
Based on aggregated 13F filings for Q1 2026.